Literature DB >> 19107746

Angiogenic effect of saponin extract from Panax notoginseng on HUVECs in vitro and zebrafish in vivo.

Si-Jia Hong1, Jian-Bo Wan, Yi Zhang, Guang Hu, Hui-Chao Lin, Sai Wang Seto, Yiu-Wa Kwan, Zhi-Xiu Lin, Yi-Tao Wang, Simon Ming-Yuen Lee.   

Abstract

Angiogenesis plays an important role in a wide range of physiological processes such as wound healing and fetal development. In fact, many diseases are associated with imbalance in the regulation of angiogenesis in which there is either excessive or insufficient blood vessel formation. Panax notoginseng, a blood circulation invigorating herb, is commonly used in traditional Chinese medicine to treat circulation-related diseases. However, the biological effects of saponin extract from Panax notoginseng (PNS) on angiogenesis and the underlying mechanisms are yet to be fully elucidated. This investigation describes the angiogenic effects of PNS on human umbilical vein endothelial cells (HUVECs) in vitro and zebrafish in vivo. The 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)5[(phenylamino)carbonyl]2H-tetrazolium hydroxide (XTT) assay and microscopic cell counting demonstrated that the extract was able to stimulate the proliferation of HUVECs. Meanwhile, the numbers of invaded cells and tube branches were significantly increased in PNS treatment groups. PNS was also shown to promote changes in the subintestinal vessels, a feature of angiogenesis, in zebrafish. In addition, by using real-time polymerase chain reaction (PCR), PNS was found to enhance vascular endothelial growth factor (VEGF) and kinase-domain region/fetal liver kinase-1 in mice (KDR/Flk-1) mRNA expression, and the PNS-induced HUVECs proliferation could be abolished by a KDR/Flk-1 inhibitor. Furthermore, the proliferation of HUVECs induced by PNS was significantly attenuated by inhibitors of PI3K-Akt-eNOS. All the results suggest that PNS can promote angiogenesis, and that the proangiogenic effects involve the VEGF-KDR/Flk-1 and PI3K-Akt-eNOS signaling pathways.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19107746     DOI: 10.1002/ptr.2705

Source DB:  PubMed          Journal:  Phytother Res        ISSN: 0951-418X            Impact factor:   5.878


  28 in total

1.  Panax notoginseng stimulates alkaline phosphatase activity, collagen synthesis, and mineralization in osteoblastic MC3T3-E1 cells.

Authors:  Zhe Ji; Yizhao Cheng; Puwei Yuan; Xiaoqian Dang; Xiong Guo; Weizhuo Wang
Journal:  In Vitro Cell Dev Biol Anim       Date:  2015-04-23       Impact factor: 2.416

2.  Whole extracts of Radix Achyranthis Bidentatae and Radix Cyathulae promote angiogenesis in human umbilical vein endothelial cells in vitro and in zebrafish in vivo.

Authors:  Xuelin Zhou; Wing-Sum Siu; Cheng Zhang; Cheuk-Lun Liu; Ling Cheng; Hin-Fai Kwok; Chak-Hei Fung; Jacqueline Chor-Wing Tam; Ching-Po Lau; Clara Bik-San Lau; Ping-Chung Leung; Leung-Kim Hung; Chun-Hay Ko
Journal:  Exp Ther Med       Date:  2017-01-17       Impact factor: 2.447

3.  Exploring mechanisms of Panax notoginseng saponins in treating coronary heart disease by integrating gene interaction network and functional enrichment analysis.

Authors:  Gui Yu; Jie Wang
Journal:  Chin J Integr Med       Date:  2016-05-16       Impact factor: 1.978

4.  Total saponins of panaxnotoginseng promotes lymphangiogenesis by activation VEGF-C expression of lymphatic endothelial cells.

Authors:  Jinlong Li; Yan Chen; Li Zhang; Lianping Xing; Hao Xu; Yongjun Wang; Qi Shi; Qianqian Liang
Journal:  J Ethnopharmacol       Date:  2016-08-21       Impact factor: 4.360

5.  Panax notoginseng saponins inhibits atherosclerotic plaque angiogenesis by down-regulating vascular endothelial growth factor and nicotinamide adenine dinucleotide phosphate oxidase subunit 4 expression.

Authors:  Yun Qiao; Peng-Ju Zhang; Xiao-ting Lu; Wei-wei Sun; Gui-lin Liu; Min Ren; Lei Yan; Ji-dong Zhang
Journal:  Chin J Integr Med       Date:  2014-03-06       Impact factor: 1.978

6.  Marine cyclotripeptide X-13 promotes angiogenesis in zebrafish and human endothelial cells via PI3K/Akt/eNOS signaling pathways.

Authors:  Xi-Lin Lu; Zhong-Liang Xu; Xiao-Li Yao; Feng-Juan Su; Cheng-Hui Ye; Jing Li; Yong-Cheng Lin; Guang-Lei Wang; Jin-Sheng Zeng; Ru-Xun Huang; Jing-Song Ou; Hong-Shuo Sun; Li-Ping Wang; Ji-Yan Pang; Zhong Pei
Journal:  Mar Drugs       Date:  2012-06-07       Impact factor: 6.085

7.  Comparative study on saponin fractions from Panax notoginseng inhibiting inflammation-induced endothelial adhesion molecule expression and monocyte adhesion.

Authors:  Nan Wang; Jian-Bo Wan; Shun-Wan Chan; Yan-Hui Deng; Nan Yu; Qing-Wen Zhang; Yi-Tao Wang; Simon Ming-Yuen Lee
Journal:  Chin Med       Date:  2011-10-13       Impact factor: 5.455

Review 8.  Systematic Review and Meta-Analysis on Randomized Controlled Trials on Efficacy and Safety of Panax Notoginseng Saponins in Treatment of Acute Ischemic Stroke.

Authors:  Liu-Ding Wang; Zhen-Min Xu; Xiao Liang; Wen-Ran Qiu; Shao-Jiao Liu; Ling-Ling Dai; Ye-Fei Wang; Chun-Yan Guo; Xiang-Hua Qi; Jian Wang; Yan-Bing Ding; Yun-Ling Zhang; Xing Liao
Journal:  Evid Based Complement Alternat Med       Date:  2021-07-09       Impact factor: 2.629

9.  From omics to drug metabolism and high content screen of natural product in zebrafish: a new model for discovery of neuroactive compound.

Authors:  Ming Wai Hung; Zai Jun Zhang; Shang Li; Benson Lei; Shuai Yuan; Guo Zhen Cui; Pui Man Hoi; Kelvin Chan; Simon Ming Yuen Lee
Journal:  Evid Based Complement Alternat Med       Date:  2012-08-05       Impact factor: 2.629

10.  Cardiovascular Diseases and Panax ginseng: A Review on Molecular Mechanisms and Medical Applications.

Authors:  Jong-Hoon Kim
Journal:  J Ginseng Res       Date:  2012-01       Impact factor: 6.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.